Google+ Facebook Twitter Twitter

Mutations in blood stem cells and colon cancer

US scientists have found how common age-related changes in the blood system can make certain colon cancers grow faster.

The study also suggests how these effects might be targeted to reduce tumour growth.

As we age, the haematopoietic stem cells in the bone marrow that give rise to all of the body’s different blood cells gradually acquire mutations in their DNA.

Most of these mutations have no effect, but some can enhance a particular stem cell’s ability to survive and proliferate, resulting in large numbers of blood cells that carry the same mutation.

This phenomenon, known as clonal haematopoiesis, is seen in 10%–20% of elderly people and is associated with an increased risk of developing blood cancers.

But clonal haematopoiesis is more frequently seen in patients with many other types of cancer.

Guryanova and colleagues decided to investigate the role of clonal haematopoiesis in colitis-associated colon cancer (CAC). Inflammatory bowel disease (IBD) is a well-known risk factor for colon cancer, and clonal haematopoiesis is prevalent in both IBD and colon cancer patients.

They found clonal haematopoiesis promotes the development of CAC by increasing the number of blood vessels that supply the intestinal tumours with nutrients and oxygen. Blocking the formation of these extra blood vessels with axitinib, a drug to treat advanced kidney cancer, inhibited the growth of CAC tumours in mice with clonal haematopoiesis.

Image credit | Science-Photo-Library


Related Articles

VR-headset - CREDIT -getty

Improving transfusion with training

Ruth Evans and Laura Eastwood from NHS Blood and Transplant discuss virtual reality training for blood transfusion testing.

red blood cells CREDIT-iStock-1227353965

Casestudy acquired protein s deficiency

Healthcare Science Section Lead in Haematology and Haemostasis Michelle Bolam presents a case study in which a two-year-old presented with an unprovoked extensive deep vein thrombosis.

paper cuts - CREDIT - Richard-Gleed

DNA: Cutting the future of genome editing

The latest CRISPR-Cas technology has been used to eliminate all traces of HIV from infected cells in the lab. Here we look at how gene editing could revolutionise clinical treatments and ask what the limitations are for its future use.

Training officer support forums-CREDIT-istock-1553163814

Training Officer Support Forums 2024

IBMS Executive Head of Education Sue Jones discusses the brand-new series of Training Officer Support Forums that will be running throughout the year.